• ICER, TrialScope, ClinOne, And More: News From February 2020

    Clinical Research News | February was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from ICER, TrialScope, ClinOne, and more.

    Feb 27, 2020

  • Merck’s Perspective On Why Health Literacy Matters

    Clinical Research News | At Merck, the job of ensuring patient information about medicines and diseases is easy to understand falls to the one-person team of Global Health Literacy Director Laurie Myers, MBA, and she’s adamant that best practices in the field need to be shared. “Patients have the right to understand information to make informed and empowered decisions,” she said during her plenary keynote at the 11th Annual Summit for Clinical Ops Executives (SCOPE) last week in Orlando.

    Feb 26, 2020

  • Effective Risk Management When Using eCOA and ePRO

    Clinical Research News Contributed Commentary | The use of direct source data capture in clinical research is on the rise, both during clinic visits and remotely by patients. This includes investigator-led and patient self-assessments using laptops or tablet devices, patient diary information using hand-held mobile devices, and wearable sensors that automatically record and transmit various health-related measurements (glucose levels, heart rate, etc.).

    Feb 25, 2020

  • Clinical Research As A Scientific Discipline: Birthing A Movement

    Clinical Research News |ORLANDO—A day ahead of the 2020 Summit for Clinical Ops Executives (SCOPE), stakeholders from across the clinical trials enterprise convened for a campfire-style chat on ways to elevate the status of clinical research as a scientific discipline and foster collaboration and pre-competitive knowledge sharing to improve trial conduct. The SCOPE Scientific Symposium (SSS) was led by a half dozen leaders from AbbVie, Pfizer, Biogen, Boston Millennia Partners (BMP), and the Tufts Center for the Study of Drug Development (CSDD), with more than 50 others actively engaged in the dialogue.

    Feb 20, 2020

  • TrialScout Receives Top Honor At SCOPE’s Participant Engagement Awards

    Clinical Research News | TrialScout receives the 2020 Participant Engagement Award for its #FindtheFive campaign, a social media campaign that uses TrialScout’s platform to harness the input from the over five million Americans that have participated in some form of clinical research over the past ten years.

    Feb 19, 2020

  • IBM Watson Health Launches Study Design and Authoring Tool

    Clinical Research News| ORLANDO--IBM Watson Health today unveiled its newest cloud-based technology, IBM Study Advance, at the 11th Annual Summit for Clinical Ops Executives (SCOPE) in Orlando, Florida. The data-driven study design and authoring tool optimizes clinical trial protocol design by merging automated access to real-world patient population data, standardizing protocol template guidance and providing a collaborative workspace designed to facilitate efficiency.

    Feb 18, 2020

  • Phage Therapy Comes Of Age

    Clinical Research News | Five years ago, phage therapy was a largely unknown approach to treating recalcitrant bacterial infections outside of Eastern Europe. But headline-grabbing stories of bacteriophages bringing people back from the brink of death has catalyzed interest in the century-old practice of using viruses to infect and kill disease-causing bacteria—especially now antimicrobial resistance has limited the usefulness of many antibiotics.

    Feb 17, 2020

  • Phages Provide Safety Net In Post-Antibiotic Era

    Clinical Research News | To fully appreciate the potential of Adaptive Phage Therapeutics (APT), it’s helpful to review history through the lens of company co-founder and Chief Scientific Officer Carl Merril. For nearly five decades, Carl has been championing the idea of using bacteriophages to treat infectious diseases—an idea for which he has been variably applauded, questioned, ignored, scolded, and, ultimately, vindicated.

    Feb 13, 2020

  • Undoing Antibiotic Resistance With Phage Therapy

    Clinical Research News | Perhaps no academic institution has worked longer on the clinical application of phages than Yale University where research efforts are focused on using the pathogen-fighting viruses to re-sensitize bacteria to the antibiotics they’ve grown resistant to. “We’re hoping to drive evolution in the other direction to preserve our antibiotic arsenal for longer,” says Benjamin Chan, Ph.D., associate research scientist in the department of ecology and evolutionary biology, who maintains a large natural-phage library.

    Feb 12, 2020